• Citer

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study.

par Durez, Patrick ;Van Den Bosch, Filip;Corluy, L;Veys, Eric M;De Clerck, L;Peretz, Anne ;Malaise, Michel;Devogelaer, Jean-Pierre;Vastesaeger, N;Geldhof, A;Westhovens, R
Référence Rheumatology, 44, 4, page (465-468)
Publication Publié, 2005-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study.
Auteur:	Durez, Patrick; Van Den Bosch, Filip; Corluy, L; Veys, Eric M; De Clerck, L; Peretz, Anne; Malaise, Michel; Devogelaer, Jean-Pierre; Vastesaeger, N; Geldhof, A; Westhovens, R
Informations sur la publication:	Rheumatology, 44, 4, page (465-468)
Statut de publication:	Publié, 2005-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antibodies, Monoclonal -- administration & dosage -- therapeutic use
	Antirheumatic Agents -- administration & dosage -- therapeutic use
	Arthritis, Rheumatoid -- drug therapy
	Drug Administration Schedule
	Drug Monitoring -- methods
	Humans
	Infusions, Intravenous
	Middle Aged
	Prospective Studies
	Severity of Illness Index
	Treatment Outcome
Note générale:	Evaluation Studies
	Journal Article
	Multicenter Study
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1462-0324
	info:doi/10.1093/rheumatology/keh494
	info:pii/keh494
	info:scp/18744394344
	info:pmid/15695306